Cargando…

Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation

Targeting the function of epidermal growth factor receptor (EGFR) has failed as an effective clinical option for breast cancer. Understanding the drivers of inherent resistance has been a challenge. One possible mechanism is the acquisition of stem-like properties through the process of epithelial-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Wells S, Wendt, Michael K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728772/ https://www.ncbi.nlm.nih.gov/pubmed/25255930 http://dx.doi.org/10.1186/s13058-014-0448-0

Ejemplares similares

AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer - culprits for resistance to EGFR inhibitors?
por: Heideman, Marinus R, et al.
Publicado: (2013)

α(V)β(6) Integrin: An Intriguing Target for COVID‐19 and Related Diseases
por: Bugatti, Kelly
Publicado: (2021)

Situation of Occupational and Environmental Health in Mexico
por: Palacios Nava, Martha Edilia, et al.
Publicado: (2018)

Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
por: Cruz da Silva, Elisabete, et al.
Publicado: (2019)

Radioiodine therapy in differentiated thyroid cancer. There is (still) a great chaos under heaven: is the situation excellent?
por: Giovanella, Luca
Publicado: (2023)

The evolution of Brazilian Health Sciences and the present situation
por: de Carvalho, Antonio Carlos Campos, et al.
Publicado: (2021)

Internet Medical Usage in Japan: Current Situation and Issues
por: Tatsumi, Haruyuki, et al.
Publicado: (2001)

The Current Situation and Future Prospects of Simulators in Dental Education
por: Li, Yaning, et al.
Publicado: (2021)

COVID-19 in Egypt: Uncovered figures or a different situation?
por: Medhat, Mohammed A, et al.
Publicado: (2020)

Codeveloping a Virtual Patient Simulation to Foster Nurses’ Relational Skills Consistent With Motivational Interviewing: A Situation of Antiretroviral Therapy Nonadherence
por: Rouleau, Geneviève, et al.
Publicado: (2020)

Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
por: Yamaoka, Toshimitsu, et al.
Publicado: (2017)

New insights into integrin signalling: implications for rheumatoid arthritis synovial fibroblasts
por: Pap, Thomas
Publicado: (2003)

Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand
por: Ali, Remah, et al.
Publicado: (2018)

Somatic Symptom Disorder Patients Seeking Aesthetic Procedures: Tricky Situations in Clinical Practice
por: Wang, Hayson Chenyu, et al.
Publicado: (2020)

Situation of physical activity in the prevention of non-communicable diseases in Bhutan: challenges and the way forward
por: Tamang, Monu, et al.
Publicado: (2022)

Why We Are Losing the War Against COVID-19 on the Data Front and How to Reverse the Situation
por: Prieto-Merino, David, et al.
Publicado: (2021)

Ip-10 Inhibits Epidermal Growth Factor–Induced Motility by Decreasing Epidermal Growth Factor Receptor–Mediated Calpain Activity
por: Shiraha, Hidenori, et al.
Publicado: (1999)

Toward the Development of an Integrated Climate-Sensitive Disease Surveillance in Southeast Asian Countries: A Situational Analysis
por: Yasobant, Sandul, et al.
Publicado: (2020)

Improving maternal and newborn health and reducing stillbirths in the Western Pacific Region – current situation and the way forward
por: Vallely, Lisa M., et al.
Publicado: (2022)

An eHealth Framework for Managing Pediatric Growth Disorders and Growth Hormone Therapy
por: Dimitri, Paul, et al.
Publicado: (2021)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

Estrogen receptor degradation: a CUE for endocrine resistance?
por: Musgrove, Elizabeth A
Publicado: (2011)

Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004)

Back to Basics: PCSK9 as a New Target for the LDL Receptor
por: Corral, Pablo
Publicado: (2014)

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Faller, Bryan A, et al.
Publicado: (2009)

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
por: Aebi-Popp, Karoline, et al.
Publicado: (2016)

Conservative fluid therapy in septic shock: an example of targeted therapeutic minimization
por: Chen, Catherine, et al.
Publicado: (2014)

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Expanding the reach of HER2-targeted therapies: transformation of an historical paradigm
por: Cobain, Erin F., et al.
Publicado: (2022)

Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?
por: Westermarck, Jukka
Publicado: (2023)

Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion
por: Witton, Caroline J
Publicado: (2003)

Squamous cell carcinomas in linear epidermal naevi
por: Dubois, A., et al.
Publicado: (2018)

Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?
por: Egi, Moritoki, et al.
Publicado: (2009)

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
por: Jönsson, Linus, et al.
Publicado: (2023)

An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
por: Elshazly, Ahmed M., et al.
Publicado: (2022)

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
por: Caramella, Irene, et al.
Publicado: (2022)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors
por: Uprety, Dipesh, et al.
Publicado: (2020)

Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
por: Wainberg, Mark A, et al.
Publicado: (2015)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Epidermal growth factor-mediated Rab25 pathway regulates integrin β1 trafficking in colon cancer
por: Hong, Kyung Sook, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kgdpsao7cp9qdhlfhdto10drh2